Zenoxa 450 Tablet contains Oxcarbazepine 450 mg, an anticonvulsant medication primarily used in the management of epilepsy. It is indicated for the treatment of partial seizures with or without secondary generalization in adults and children aged 4 years and above. Oxcarbazepine acts by stabilizing hyperexcited neural membranes, inhibiting repetitive neuronal firing, and reducing the propagation of seizure activity through modulation of voltage-sensitive sodium channels. This mechanism helps to prevent the abnormal electrical activity in the brain responsible for seizures. Zenoxa 450 is typically administered orally, with dosage individualized based on patient response and tolerability. Common side effects may include dizziness, somnolence, headache, nausea, and hyponatremia; therefore, periodic monitoring of serum sodium levels is recommended, especially during the initial treatment phase. Caution is advised in patients with a history of hypersensitivity to carbamazepine or related compounds, as cross-reactivity may occur. Additionally, patients should be monitored for signs of allergic reactions or dermatological adverse effects. Zenoxa 450 should be used under strict medical supervision, with careful consideration of drug interactions, particularly with other antiepileptic drugs, to optimize therapeutic outcomes and minimize adverse effects.